The first phase of construction of the Avexima pharmaceutical company plant, which will be located in Esipovo Industrial Park in Moscow-region Solnechnogorsk, is scheduled for 2024-2025. The complex has an area of 60,000 sq. m. and will include laboratories, a production workshop and a warehouse, the press service of the municipality administration reports.
At the first stage of construction, the investments will amount to 3 billion rubles, and in total it is planned to allocate at least 6.5 billion rubles for the implementation of the project. After commissioning, the company will develop and manufacture drugs, including antibiotics and antitumor agents.
Avexima is one of Russia’s largest manufacturers of active pharmaceutical substances and finished pharmaceutical products, which operates at the facilities of the oldest pharmaceutical plants: the Irbit Chemical and Pharmaceutical Plant in the Sverdlovsk region and Avexima Siberia in the Kemerovo region. Plans of creating a factory from scratch in the Moscow region were announced as early as in 2017.
